Mauricio García-Saenz-de-Sicilia
Associate Professor, Division Chief
Also affiliated: University of Nebraska at Omaha (2018); University of Iowa (2018); Nebraska Medical Center (2012); University of Miami (2018); Washington University in St. Louis (2021–2022); University of Arkansas Medical Center (2019); Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (2008–2010); Regione Siciliana (2016); Directorate-General for Interpretation (2016); Creative Research Enterprises (United States) (2018); University of Nebraska Medical Center (2012)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Mauricio García-Saenz-de-Sicilia's research focuses on the medical management of advanced liver disease and liver transplantation. His work investigates strategies for risk stratification in liver transplant candidates, including the use of computed tomography coronary calcium scores for coronary artery disease assessment and cystatin C for evaluating kidney dysfunction and survival. García-Saenz-de-Sicilia also studies endoscopic management techniques for gastric neoplasms and the role of alpha-fetoprotein in liver allocation for transplantation. His recent publications address emerging areas such as endohepatology and the application of drug-coated balloons in cardiovascular interventions within the context of solid organ transplantation. He has authored 42 publications, with a total of 475 citations, and holds an h-index of 12. García-Saenz-de-Sicilia collaborates with researchers at the University of Arkansas for Medical Sciences, including Ragesh B. Thandassery and Sushma Bhusal.
Metrics
- h-index: 12
- Publications: 42
- Citations: 487
Selected Publications
-
Drug-coated balloon angioplasty with a focus on solid organ transplantation: a promising paradigm shift in cardiovascular interventions (2026)
-
Metastatic Jejunal Adenocarcinoma in the Hepatobiliary Limb Post-Liver Transplant: Diagnostic Challenges in a Patient with Roux-en-Y Gastric Bypass (2024)
-
Evaluating Disparities in <scp>COVID</scp>‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study (2024)
-
Prospective evaluation of cystatin C in the assessment of kidney dysfunction and survival in liver transplant candidates (2024)
-
Recent advances in endoscopic management of gastric neoplasms (2023)
-
Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future (2022)
-
Endohepatology: current status and perspectives (2022)
-
Abnormal liver enzymes in a liver transplant recipient (2020)
-
Is combining therapy with indomethacin and epinephrine useful for preventing post-ERCP pancreatitis? The answer from a meta-analysis (2020)
-
2219 Chronic Active Epstein-Barr Virus Presenting Primarily With Abnormal Liver Enzymes (2019)
-
2218 Recurrent Hepatocellular Carcinoma From Needle Tract Seeding 13 Years Post-Transplant (2019)
-
1666 A Rare Case of Colonic Malakoplakia in an Immunocompetent Man With Prior Chronic Hepatitis C Virus Infection (2019)
-
98 Combination Rectal Indomethacin and Topical Epinephrine Is Not Superior to Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis—A Meta-Analysis (2019)
-
870 The Efficacy and Safety of Endoscopic Submucosal Dissection for Early Gastric Cancer in Patients With Cirrhosis: A Systematic Review and Meta-Analysis (2019)
-
Hemoglobin A1c Has Suboptimal Performance to Diagnose and Monitor Diabetes Mellitus in Patients with Cirrhosis (2018)
Collaboration Network
Top Collaborators
- Recent advances in endoscopic management of gastric neoplasms
- Evaluating Disparities in <scp>COVID</scp>‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Endohepatology: current status and perspectives
- Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future
- Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future
- Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future
- Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future
- Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future
- Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future
- Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future
- Recent advances in endoscopic management of gastric neoplasms
- Recent advances in endoscopic management of gastric neoplasms
- Recent advances in endoscopic management of gastric neoplasms
- Prospective evaluation of cystatin C in the assessment of kidney dysfunction and survival in liver transplant candidates
- Prospective evaluation of cystatin C in the assessment of kidney dysfunction and survival in liver transplant candidates
- Prospective evaluation of cystatin C in the assessment of kidney dysfunction and survival in liver transplant candidates
Similar Researchers
Based on overlapping research topics